CRL — Charles River Laboratories International Share News
0.000.00%
Last trade - 00:00- $14.62bn
- $17.10bn
- $4.02bn
Charles River climbs after lifting annual profit forecast
Charles River lifts profit forecast on improving biotech demand
Charles River Laboratories tops Q2 revenue and profit estimates
U.S. STOCKS ON THE MOVE-Natera, nLIGHT, Micron
U.S. STOCKS ON THE MOVE-Natera, nLIGHT, Forte Biosciences
U.S. STOCKS ON THE MOVE-Levi's, Meta, PepsiCo
U.S. STOCKS ON THE MOVE-Levi, Ionis Pharmaceuticals, Gloo Holdings
TD Cowen sees improving demand for contract research firms in Q2 2026
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT
Brief: Charles River Laboratories International Announces Collaboration With Lilly Tunelab
Brief: Charles River Laboratories And Medipost Sign Non-Exclusive MoU To Advance Gmp Testing Solutions
U.S. RESEARCH ROUNDUP-Applied Materials, McDonald's, McKesson
Charles River beats quarterly estimates on steady demand for drug development services
Charles River Q1 revenue and adjusted EPS beat estimates
U.S. RESEARCH ROUNDUP-3M, CME Group, Transdigm Group
AI-led selloff in contract research firms may be misjudging disruption risk
Iqvia Rises As It Buys Charles River's Early: stage drug research assets
Charles River raises annual profit view as it sells underperforming assets
U.S. RESEARCH ROUNDUP-Dropbox, Etsy, Zscaler